Under utilisation of evidence-based treatment partially explains for the unfavourable prognosis in diabetic patients with acute myocardial infarction

European Heart Journal

Volumn 24, Issue 9, 2003, Pages 838-844

  Norhammar, Anna ^a   Malmberg, Klas ^a   Rydén, Lars ^a   Tornvall, Per ^a   Stenestrand, Ulf ^b   Wallentin, Lars ^c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Acute myocardial; Diabetes mellitus; Evidence based; Infarction; Prognosis; Treatment

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOLYTIC AGENT; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY CARE UNIT; DIABETES MELLITUS; DRUG USE; EVALUATION; EVIDENCE BASED MEDICINE; FEMALE; HEALTH CARE UTILIZATION; HEART MUSCLE REVASCULARIZATION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REGISTRATION; SURVIVAL TIME; SWEDEN;

ADULT; AGED; COHORT STUDIES; DIABETIC ANGIOPATHIES; EVIDENCE-BASED MEDICINE; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; REGISTRIES; REGRESSION ANALYSIS; SURVIVAL ANALYSIS;

EID: 0037965978     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-668X(02)00828-X     Document Type: Article

References (22)

1. Malmberg K, Rydén L. Myocardial infarction in patients with diabetes mellitus. Eur Heart J 1988;9:259-64.
2. Herlitz J, Malmberg K, Karlsson BW et al. Mortality and morbidity during a five-year follow-up of diabetics with myocardial infarction. Acta Med Scand 1988;224:31-8.
3. Gu K, Cowie CC, Harris MI. Diabetes and decline in heart disease mortality in US adults. JAMA 1999;281:1291-7.
4. Caramelli B, Tranchesi B, Gebara OCE et al. Retinal haemorrhage after thrombolytic therapy. Lancet 1991;337:1356-7.
5. Sunderraj P. Intraocular haemorrhage associated with intravenously administrated streptokinase. Am J Ophtalmol 1991;112:734-5.
6. Clausen-Sjöborn N, Lins P, Adamsson U et al. Effect of metoprolol on the counterregulation and recognition of prolonged hypoglycemia in insulin-dependent diabetics. Acta Med Scand 1987;222:57-63.
7. Lager I, Smith U, Blohme G. Effect of cardioselective and nonselective betablockade on the hypoglycemic response in insulin dependent diabetics. Lancet 1979;1:458-62.
8. Malmberg K, Herlitz J, Hjalmarson A et al. Effects of metoprolol on mortality and late infarction in diabetics with suspected acute myocardial infarction. Retrospective data from two large studies. Eur Heart J 1989;10:423-8.
9. Gundersen T, Kjekshus K. Timolol treatment after myocardial infarction in diabetic patients. Diabetes Care 1983;6:285-90.
10. Malmberg K, Ryden L, Efendic S et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol 1995;26:57-65.
11. Malmberg K, for the DIGAMI study group. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mettitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. BMJ 1997;314:1512-5.
12. Malmberg K, Norhammar A, Wedel H et al. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mettitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 1999;99:2626-32.
13. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P et al. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Circulation 1994;90:583-612.
14. Cox D. Regression models and life-tables. J R Stat Soc (B) 1972;34:187-220.
15. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Acute myocardial infarction: pre-hospital and in-hospital management. Eur Heart J 1996;17:43-63.
16. Ryan TJ, Andersson JL, Antman EM et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction: executive summary. Circulation 1996;94:2341-50.
17. Fibrinotytic Therapy Triatists (FFT) Collaborative Group. Indication for fibrinolytic therapy in suspected acute myocardiat infarction: collaborative overview of early mortality and major morbidity results form all randomised trials of more than 1000 patients. Lancet 1994;343:311-22.
18. Stenestrand U, Wallentin L, for the Swedish Register of Cardiac Intensive Care (RIKS-HIA). Early statin treatment following acute myocardial infarction and 1-year survival. JAMA 2001;285:430-6.
19. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-9.
20. The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, Ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000;342:134-53.
21. Rodrigues B, McNeill JH. The diabetic heart: metabolic causes for the development of a cardiomyopathy. Cardiovasc Res 1992;26:913-22.
22. van den Berghe G, Wouters P, Weekers F et al. Intensive insulin therapy in the surgical intensive care unit. N Engl J Med 2001;345:1359-67.